- Research Tracker
- Evidence-gap maps
For each condition, a matrix of non-drug approaches against the outcomes trials have measured. Empty cells show where no matching trial was found among those searched, and weak cells where trials have posted no results. Built from 19,258 ClinicalTrials.gov records.
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.
| Condition | Trials | Results posted | Top possible gap |
|---|---|---|---|
| Acne Vulgaris | 46 | 3 | – |
| Age-Related Macular Degeneration | 87 | 10 | Among the 30 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (6 trials of other approaches did). |
| Alcohol Abuse | 262 | 59 | Among the 23 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (11 trials of other approaches did). |
| Alopecia Areata | 32 | 0 | Among the 13 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did). |
| Alpha-1 Antitrypsin Deficiency | 2 | 0 | – |
| Alzheimer's Disease and Other Dementias | 14 | 6 | – |
| Amyotrophic Lateral Sclerosis | 94 | 12 | Among the 10 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (22 trials of other approaches did). |
| Ankylosing Spondylitis | 57 | 1 | – |
| Anxiety | 589 | 17 | not shown: search capped |
| Asthma | 462 | 78 | not shown: search capped |
| Atopic Eczema | 112 | 2 | Among the 10 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (12 trials of other approaches did). |
| Atrial Fibrillation | 148 | 15 | not shown: search capped |
| Attention Deficit-Hyperactivity Disorder | 475 | 48 | not shown: search capped |
| autoimmune gastritis | 0 | 0 | – |
| Benign Prostatic Hyperplasia | 39 | 2 | – |
| Beta Thalassemia | 23 | 1 | – |
| Bipolar Disorder | 473 | 73 | Among the 13 trials of care delivery and health services found, none used cognition as a primary outcome (58 trials of other approaches did). |
| Bladder Cancer | 123 | 17 | Among the 15 trials of exercise and physical activity found, none used symptom severity and disease activity as a primary outcome (17 trials of other approaches did). |
| Breast Cancer | 498 | 55 | not shown: search capped |
| Cancer | 318 | 33 | not shown: search capped |
| Carpal Tunnel Syndrome | 146 | 2 | Among the 26 trials of rehabilitation and therapy services found, none used inflammation and other biomarkers as a primary outcome (9 trials of other approaches did). |
| Celiac Disease | 88 | 6 | Among the 39 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (7 trials of other approaches did). |
| Cervical Cancer | 289 | 22 | not shown: search capped |
| Chronic Kidney Disease | 386 | 53 | not shown: search capped |
| Chronic Lymphocytic Leukemia | 54 | 9 | Among the 11 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (8 trials of other approaches did). |
| Chronic Obstructive Pulmonary Disease | 309 | 28 | not shown: search capped |
| Chronic Pancreatitis | 28 | 3 | – |
| Chronic Spontaneous Urticaria | 5 | 0 | – |
| Chronic Venous Insufficiency | 30 | 6 | – |
| Colorectal Cancer | 389 | 30 | not shown: search capped |
| Cystic Fibrosis | 202 | 16 | Among the 19 trials of mind-body and psychological approaches found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did). |
| Dermatomyositis | 9 | 0 | – |
| Diabetic Neuropathy | 299 | 17 | not shown: search capped |
| Endometriosis | 103 | 5 | Among the 12 trials of supplements and nutraceuticals found, none used symptom severity and disease activity as a primary outcome (17 trials of other approaches did). |
| Epilepsy | 349 | 28 | Among the 30 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did). |
| Essential Hypertension | 78 | 1 | Among the 18 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (3 trials of other approaches did). |
| Fibromyalgia | 474 | 26 | Among the 9 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (74 trials of other approaches did). |
| Gastroesophageal Reflux Disease | 96 | 2 | Among the 12 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (14 trials of other approaches did). |
| Gastroparesis | 27 | 5 | – |
| Glaucoma | 117 | 13 | Among the 23 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (8 trials of other approaches did). |
| Gout | 32 | 7 | Among the 8 trials of supplements and nutraceuticals found, none used pain as a primary outcome (4 trials of other approaches did). |
| Gulf War Illness | 26 | 11 | – |
| Heart Failure | 364 | 27 | not shown: search capped |
| Hemophilia | 43 | 2 | Among the 11 trials of oxygen, light, temperature and manual therapies found, none used symptom severity and disease activity as a primary outcome (5 trials of other approaches did). |
| Hepatitis B | 47 | 6 | Among the 8 trials of cognitive training and education found, none used clinical events, survival and healthcare use as a primary outcome (7 trials of other approaches did). |
| Hepatitis C | 148 | 26 | Among the 21 trials of supplements and nutraceuticals found, none used symptom severity and disease activity as a primary outcome (12 trials of other approaches did). |
| HIV/AIDS | 627 | 131 | not shown: search capped |
| Huntington Disease | 39 | 5 | Among the 11 trials of supplements and nutraceuticals found, none used cognition as a primary outcome (4 trials of other approaches did). |
| Hypothyroidism | 19 | 0 | – |
| Immune Thrombocytopenia | 3 | 0 | – |
| Inflammatory Bowel Disease | 249 | 11 | not shown: search capped |
| Insomnia | 345 | 24 | not shown: search capped |
| Interstitial Cystitis | 30 | 6 | Among the 9 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (3 trials of other approaches did). |
| Irritable Bowel Syndrome | 382 | 18 | Among the 17 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (43 trials of other approaches did). |
| Ischemic Stroke | 297 | 21 | not shown: search capped |
| Kidney Stones | 83 | 11 | Among the 8 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (11 trials of other approaches did). |
| Long COVID | 243 | 13 | Among the 27 trials of oxygen, light, temperature and manual therapies found, none used breathing and lung function as a primary outcome (28 trials of other approaches did). |
| Low Back Pain | 636 | 27 | not shown: search capped |
| Lung Cancer | 315 | 34 | not shown: search capped |
| Lupus Nephritis | 4 | 0 | – |
| Lyme Disease | 11 | 4 | – |
| Lyme disease and post-treatment Lyme disease syndrome | 11 | 4 | – |
| Major Depressive Disorder | 590 | 60 | not shown: search capped |
| Mast Cell Activation Syndrome | 6 | 2 | – |
| Mast Cell Activation Syndrome | 1 | 0 | – |
| Mastocytosis with KIT D816V Mutation | 0 | 0 | – |
| Measles | 10 | 1 | – |
| Melanoma | 133 | 24 | Among the 10 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (19 trials of other approaches did). |
| Metabolic Dysfunction-Associated Steatohepatitis | 38 | 1 | – |
| Migraine Disorder | 315 | 33 | Among the 13 trials of diet, fasting and nutrition found, none used physical function and exercise capacity as a primary outcome (55 trials of other approaches did). |
| Multiple Myeloma | 162 | 20 | Among the 26 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (19 trials of other approaches did). |
| Multiple Sclerosis | 607 | 45 | not shown: search capped |
| Myalgic Encephalomyelitis / Chronic Fatigue Syndrome | 63 | 3 | Among the 12 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (11 trials of other approaches did). |
| Myasthenia Gravis | 22 | 1 | Among the 12 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (3 trials of other approaches did). |
| Myelodysplastic Syndrome | 53 | 6 | Among the 9 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (8 trials of other approaches did). |
| Non-Hodgkin Lymphoma | 83 | 16 | not shown: search capped |
| Obesity | 668 | 62 | not shown: search capped |
| Obstructive Sleep Apnea | 473 | 62 | not shown: search capped |
| Opioid Use Disorder | 456 | 101 | Among the 27 trials of care delivery and health services found, none used pain as a primary outcome (47 trials of other approaches did). |
| Osteoarthritis | 372 | 20 | not shown: search capped |
| Osteoporosis | 344 | 50 | Among the 18 trials of diet, fasting and nutrition found, none used clinical events, survival and healthcare use as a primary outcome (29 trials of other approaches did). |
| Ovarian Cancer | 235 | 25 | not shown: search capped |
| Overactive Bladder | 123 | 11 | Among the 8 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (11 trials of other approaches did). |
| Pancreatic Cancer | 182 | 23 | not shown: search capped |
| Parkinson Disease | 490 | 46 | not shown: search capped |
| Peripheral Arterial Disease | 219 | 35 | not shown: search capped |
| Polycystic Kidney Disease | 23 | 3 | – |
| Polycystic Ovary Syndrome | 244 | 13 | Among the 28 trials of oxygen, light, temperature and manual therapies found, none used cognition as a primary outcome (14 trials of other approaches did). |
| Polycythemia Vera | 7 | 0 | – |
| Post-Acute COVID/Vaccination Syndrome | 3 | 0 | – |
| Postural Orthostatic Tachycardia Syndrome | 36 | 5 | – |
| Primary Sclerosing Cholangitis | 8 | 1 | – |
| Prostate Cancer | 305 | 36 | not shown: search capped |
| Psoriasis Vulgaris | 14 | 2 | – |
| Psoriatic Arthritis | 40 | 0 | Among the 8 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (8 trials of other approaches did). |
| Pulmonary Arterial Hypertension | 173 | 16 | Among the 13 trials of rehabilitation and therapy services found, none used heart rate, blood pressure and autonomic as a primary outcome (39 trials of other approaches did). |
| Restless Legs Syndrome | 57 | 4 | – |
| Rheumatoid Arthritis | 321 | 40 | Among the 10 trials of rehabilitation and therapy services found, none used physical function and exercise capacity as a primary outcome (59 trials of other approaches did). |
| Sarcopenia | 544 | 26 | Among the 12 trials of oxygen, light, temperature and manual therapies found, none used weight and metabolic markers as a primary outcome (87 trials of other approaches did). |
| Schizophrenia | 539 | 59 | not shown: search capped |
| Sepsis | 144 | 13 | not shown: search capped |
| Sickle Cell Disease | 171 | 36 | Among the 24 trials of supplements and nutraceuticals found, none used pain as a primary outcome (43 trials of other approaches did). |
| Sjögren's Syndrome | 13 | 0 | – |
| Systemic Lupus Erythematosus | 115 | 16 | Among the 17 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (16 trials of other approaches did). |
| Thyroid Cancer | 67 | 8 | Among the 8 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (13 trials of other approaches did). |
| Tinnitus | 158 | 23 | Among the 17 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (18 trials of other approaches did). |
| Type 1 Diabetes Mellitus | 480 | 89 | not shown: search capped |
| Type 2 Diabetes Mellitus | 677 | 61 | not shown: search capped |
| Venous Thromboembolism | 30 | 5 | – |
| Vitiligo | 23 | 5 | – |
Method: how trials are selected. A gap means no matching trial was found among those searched, not that an approach would work.